1.

Which peptide for the treatment of Alzheimer’s disease was approved by the government for phase I clinical trial?(a) Ab(b) Ab43(c) Aβ42(d) Aβ43

Answer» The correct option is (c) Aβ42

To elaborate: Researchers at the Elan pharmaceuticals published some interesting findings in which they used the Amyloid-β-42 peptide to immunize mice and saw the mitigation in symptoms of AD.


Discussion

No Comment Found

Related InterviewSolutions